The global drug screening market was valued at USD 5.8 billion in 2022, growing at a CAGR of 17.2% from 2023 to 2032. The market is expected to reach USD 28.3 billion by 2032. The main factor driving this growth of drug screening is the increasing usage of drugs and alcohol across the globe.
Drug screening assists in determining whether drugs or the products of their metabolism are present in a person's biological material, typically their blood, saliva, urine, or hair. Drug testing is frequently used by employers, healthcare professionals, and law enforcement agencies to assess drug use or abuse. This preventive action helps identify possible health risks, maintain workplace security, and comply with requirements. A laboratory examination or quick tests are usually used in the screening procedure to identify substances, including cocaine, cannabis, amphetamines, opioids, and other controlled substances. Drug screening acceptance has accelerated because of the world's rising drug abuse. Nearly 13% of the world's population, or 36.3 million people, were predicted to be affected by drug use disorders in 2019, according to the World Drug Report 2021. Drug use problems caused the loss of 18 million years of healthy living, mainly from opioids, and nearly half a million lives were lost to drug use in a single year. Extensive regulations are implemented to mitigate drug consumption.
Get an overview of this study by requesting a free sample
In April 2022, Janssen Pharmaceutical NV sold its patent portfolio for antipsychotic medication testing to Saladax Biomedical, Inc. There are seventeen patent families in this intellectual property (IP) portfolio. The company now holds a leading position in the antipsychotic drug testing industry because of this strategy.
In April 2019, Thermo Scientific CEDIA Mitragynine (Kratom) Assay, Thermo Fisher Scientific's newest drug misuse test, was introduced. With the CEDIA Mitragynine (Kratom) assay, a variety of laboratories may test for the presence of Kratom using widely used clinical chemistry analyzers. This assisted the business in diversifying its product line.
Rising workplace regulations for employees- Regular drug testing is required by strict workplace standards and employment legislation, especially in sectors where safety is a priority, like construction, transportation, and healthcare. Employers must implement drug testing programmes to comply with regulatory obligations, maintain a safe workplace, and reduce potential liabilities. This driver emphasizes how important drug testing is to preserving employee well-being, workplace safety, and adherence to industry-specific regulations.
False positives and negatives- The intricacies of human metabolism and the possibility of cross-reactivity with certain drugs present a difficulty for drug screening in terms of false positives and negatives. False positive results can happen when a test results in an inaccurate substance finding, which could have unjustified repercussions for the person. On the other hand, if a test is unable to identify real drug usage, false negatives could result. To overcome these obstacles, testing procedures must be continuously improved, individual differences must be taken into account, and stakeholders must be informed about the variables that affect test accuracy.
Technological advancements- Testing methods are expected to undergo considerable technological developments due to the drug screening market's growth. Creating testing kits that are more precise and sensitive, speedier and non-invasive screening techniques, and using cutting-edge technologies like nanotechnology or biosensors are a few examples of innovations. These developments add to a wider variety of compounds that can be detected and improve the precision and effectiveness of drug screening. Furthermore, more user-friendly testing procedures could result from enhanced technology, opening drug screening to a wider range of sectors and applications.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global drug screening market, with a 39% market revenue share in 2022.
North America is anticipated to have a sizable market share in the drug screening sector because of the grave issue associated with excessive alcohol consumption. Drug screening is also encouraged by the rising use of illegal drugs, the government's financing for the fight against drug misuse, and the nation's stringent laws. For example, between January and December 2021, Quest Diagnostics collected 11 million unidentified urine, hair, and oral fluid sample data. In April 2022, the company conducted drug testing.
North America Region Drug Screening Market Share in 2022 - 39%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The end-user segment is divided into criminal justice systems and law enforcement agencies, pain management centres, drug testing laboratories, workplaces, drug treatment centres, and others. The workplace segment dominated the market, with a market share of around 23% in 2022. The rise in workplace safety concerns and the number of organizations requiring regular drug testing can be attributed to the development of this end-user segment.
The sample type segment is divided into breath samples, hair samples, urine samples, oral fluid samples, and others. The urine samples segment dominated the market, with a market share of around 29% in 2022. The capacity to detect a high concentration of drugs in the sample and its non-invasive nature are two advantages of urine testing that are anticipated to propel the segment's expansion over the forecast period. Drug usage within a day or four, and perhaps much longer, can be detected by urine tests.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2022 | USD 5.8 Billion |
Market size value in 2032 | USD 28.3 Billion |
CAGR (2023 to 2032) | 17.2% |
Historical data | 2019-2021 |
Base Year | 2022 |
Forecast | 2023-2032 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | End-User, Sample Type |
As per The Brainy Insights, the size of the drug screening market was valued at USD 5.8 billion in 2022 to USD 28.3 billion by 2032.
The global drug screening market is growing at a CAGR of 17.2% during the forecast period 2023-2032.
North America emerged as the largest drug screening market.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by End-User
4.3.2. Market Attractiveness Analysis by Sample Type
4.3.3. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Rising workplace regulations for employees
5.3. Restraints
5.3.1. False positives and negatives
5.4. Opportunities
5.4.1. Technological advancements
5.5. Challenges
5.5.1. Preventive healthcare initiatives
6. Global Drug Screening Market Analysis and Forecast, By End-User
6.1. Segment Overview
6.2. Criminal Justice Systems and Law Enforcement Agencies
6.3. Pain Management Centers
6.4. Drug Testing Laboratories
6.5. Workplace
6.6. Drug Treatment Centers
6.7. Others
7. Global Drug Screening Market Analysis and Forecast, By Sample Type
7.1. Segment Overview
7.2. Breath Samples
7.3. Hair Samples
7.4. Urine Samples
7.5. Oral Fluid Samples
7.6. Others
8. Global Drug Screening Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Drug Screening Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Drug Screening Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Quest Diagnostics
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Thermo Fisher Scientific, Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. OraSure Technologies, Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. F. Hoffmann-La Roche Ltd
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. LifeLoc Technologies
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Premier Biotech, Inc.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. LabCorp (Laboratory Corporation of America Holdings)
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Abbott Laboratories
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Alfa Scientific Designs, Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Siemens Healthineers
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Shimadzu Corporation
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Drägerwerk AG & Co. KGaA
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
List of Table
1. Global Drug Screening Market, By End-User, 2019-2032 (USD Billion)
2. Global Criminal Justice Systems and Law Enforcement Agencies, Drug Screening Market, By Region, 2019-2032 (USD Billion)
3. Global Pain Management Centers, Drug Screening Market, By Region, 2019-2032 (USD Billion)
4. Global Drug Testing Laboratories, Drug Screening Market, By Region, 2019-2032 (USD Billion)
5. Global Workplace, Drug Screening Market, By Region, 2019-2032 (USD Billion)
6. Global Drug Treatment Centers, Drug Screening Market, By Region, 2019-2032 (USD Billion)
7. Global Others, Drug Screening Market, By Region, 2019-2032 (USD Billion)
8. Global Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
9. Global Breath Samples, Drug Screening Market, By Region, 2019-2032 (USD Billion)
10. Global Hair Samples, Drug Screening Market, By Region, 2019-2032 (USD Billion)
11. Global Urine Samples, Drug Screening Market, By Region, 2019-2032 (USD Billion)
12. Global Oral Fluid Samples, Drug Screening Market, By Region, 2019-2032 (USD Billion)
13. Global Others, Drug Screening Market, By Region, 2019-2032 (USD Billion)
14. North America Drug Screening Market, By End-User, 2019-2032 (USD Billion)
15. North America Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
16. U.S. Drug Screening Market, By End-User, 2019-2032 (USD Billion)
17. U.S. Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
18. Canada Drug Screening Market, By End-User, 2019-2032 (USD Billion)
19. Canada Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
20. Mexico Drug Screening Market, By End-User, 2019-2032 (USD Billion)
21. Mexico Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
22. Europe Drug Screening Market, By End-User, 2019-2032 (USD Billion)
23. Europe Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
24. Germany Drug Screening Market, By End-User, 2019-2032 (USD Billion)
25. Germany Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
26. France Drug Screening Market, By End-User, 2019-2032 (USD Billion)
27. France Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
28. U.K. Drug Screening Market, By End-User, 2019-2032 (USD Billion)
29. U.K. Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
30. Italy Drug Screening Market, By End-User, 2019-2032 (USD Billion)
31. Italy Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
32. Spain Drug Screening Market, By End-User, 2019-2032 (USD Billion)
33. Spain Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
34. Asia Pacific Drug Screening Market, By End-User, 2019-2032 (USD Billion)
35. Asia Pacific Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
36. Japan Drug Screening Market, By End-User, 2019-2032 (USD Billion)
37. Japan Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
38. China Drug Screening Market, By End-User, 2019-2032 (USD Billion)
39. China Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
40. India Drug Screening Market, By End-User, 2019-2032 (USD Billion)
41. India Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
42. South America Drug Screening Market, By End-User, 2019-2032 (USD Billion)
43. South America Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
44. Brazil Drug Screening Market, By End-User, 2019-2032 (USD Billion)
45. Brazil Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
46. Middle East and Africa Drug Screening Market, By End-User, 2019-2032 (USD Billion)
47. Middle East and Africa Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
48. UAE Drug Screening Market, By End-User, 2019-2032 (USD Billion)
49. UAE Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
50. South Africa Drug Screening Market, By End-User, 2019-2032 (USD Billion)
51. South Africa Drug Screening Market, By Sample Type, 2019-2032 (USD Billion)
List of Figures
1. Global Drug Screening Market Segmentation
2. Global Drug Screening Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Drug Screening Market Attractiveness Analysis by End-User
9. Global Drug Screening Market Attractiveness Analysis by Sample Type
10. Global Drug Screening Market Attractiveness Analysis by Region
11. Global Drug Screening Market: Dynamics
12. Global Drug Screening Market Share by End-User (2023 & 2032)
13. Global Drug Screening Market Share by Sample Type (2023 & 2032)
14. Global Drug Screening Market Share by Regions (2023 & 2032)
15. Global Drug Screening Market Share by Company (2022)
This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global drug screening market based on the below-mentioned segments:
Global Drug Screening Market By End-User:
Global Drug Screening Market By Sample Type:
Global Drug Screening Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date